Carl Zeiss Meditec (ETR:AFX) Trading Down 1% - Here's Why

Key Points

• Carl Zeiss Meditec AG shares fell by 1% during mid-day trading, closing at €42.16 ($49.60) after trading volumes increased by 59% compared to average sessions.
• The company's market capitalization stands at $3.93 billion, with a price-to-earnings ratio of 22.53 and a 50-day moving average of €44.51.
• Carl Zeiss Meditec operates in the medical technology sector, focusing on products for the diagnosis and treatment of chronic eye diseases within the Ophthalmology and Microsurgery segments.

Carl Zeiss Meditec AG (ETR:AFX - )'s share price fell 1% during mid-day trading on Wednesday . The stock traded as low as €41.68 ($49.04) and last traded at €42.16 ($49.60). 149,758 shares were traded during trading, an increase of 59% from the average session volume of 94,405 shares. The stock had previously closed at €42.60 ($50.12).

Carl Zeiss Meditec Stock Performance

The stock's 50-day moving average is €44.51 and its 200-day moving average is €53.40. The firm has a market capitalization of $3.93 billion, a price-to-earnings ratio of 22.53, a PEG ratio of 2.83 and a beta of 0.98. The company has a current ratio of 2.13, a quick ratio of 2.47 and a debt-to-equity ratio of 7.41.

About Carl Zeiss Meditec

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.